Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Drug Abuse Testing Companies

At the forefront of substance abuse prevention, Drug of Abuse Testing companies excel in research, development, and manufacturing of advanced testing solutions. Their focus lies in creating accurate and reliable diagnostic tools that aid in identifying and monitoring drug use, supporting healthcare providers, employers, and law enforcement agencies.

Drug of Abuse Testing Key Companies

Latest Drug of Abuse Testing Companies Update:

AstraZeneca acquires ADC Therapeutics: This $5.2 billion deal strengthens AstraZeneca's oncology pipeline, specifically expanding its presence in antibody-drug conjugates (ADCs) used in immunotherapy.

Pfizer returns Bavencio rights to Merck KGaA: While this shake-up might seem surprising, it allows Pfizer to focus on its core oncology portfolio and gain royalties on future Bavencio sales

Merck's Keytruda expands reach: New FDA approvals for treating non-small cell lung cancer and cervical cancer solidify Keytruda's dominance in the market.

Bristol Myers Squibb's Opdivo scores big: Opdivo, another leading checkpoint inhibitor, receives FDA approval for a new combination therapy in advanced bladder cancer

Incyte and Macrogenics report promising early-stage clinical trial results for novel immunotherapy targets, showing potential for future disruptions

List of Drug of Abuse Testing Key companies in the market

Abbott Laboratories

Quest Diagnostics Incorporated

Express Diagnostics

Thermo Fisher Scientific Inc.

Siemens AG

Pfizer

Dragerwerk AG & Co. KGAA

OraSure

Hoffmann-La Roche AG

Premier Biotech

Alfa Scientific Designs

SureHire

Lifeloc

Omega Laboratories

CannAmm

Shimadzu

Psychemedics

Laboratory Corporation of America Holdings (LabCorp)

Randox Laboratories

Sonic Healthcare

Bio-Rad Laboratories

Drug Abuse Testing Market Highlights:

Drug Abuse Testing Market Size

Drug Abuse Testing Market Trends

Drug Abuse Testing Market Analysis

Drug Abuse Testing Market Share

Drug Abuse Testing Market Highlights:

Drug Abuse Testing Market Trends

Drug Abuse Testing Market Analysis

Drug Abuse Testing Market Share

Drug Abuse Testing Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.